MULTILAYERED EXPANDABLE VASCULAR STENT

Abstract

A vascular stent including at least two layers of magnesium alloy latticed support walls, a cavity, and an expandable balloon. The expandable balloon is disposed in the cavity.

Claims

1. A vascular stent, comprising: at least two layers of magnesium alloy latticed support walls; a cavity; and an expandable balloon disposed in the cavity.

2. The stent of claim 1, wherein the latticed support walls are between 0.05 and 0.2 mm in thickness.

3. The stent of claim 1, wherein surfaces of the latticed support walls are coated with a drug-loading layer; the drug-loading layer comprises a polymer and an active component; the polymer is an ethylene-vinyl alcohol copolymer, ethylene-vinyl acetate copolymer or styrene-isobutylene block copolymer; and the active component is antiplatelet drug.

Description

BRIEF DESCRIPTION OF THE DRAWINGS

[0009] FIG. 1 is a schematic diagram of a multilayered expandable vascular stent in accordance with one embodiment of the invention;

[0010] FIG. 2 is a schematic diagram of a multilayered expandable vascular stent after being expanded in FIG. 1;

[0011] FIG. 3 is a schematic diagram of a multilayered expandable vascular stent in accordance with another embodiment of the invention; and

[0012] FIG. 4 is a schematic diagram of a multilayered expandable vascular stent after being expanded in FIG. 3.

DETAILED DESCRIPTION OF THE EMBODIMENTS

[0013] For further illustrating the invention, experiments detailing a multilayered expandable vascular stent are described hereinbelow combined with the drawings. It should be noted that the following examples are intended to describe and not to limit the invention.

[0014] As shown in FIGS. 1, 2, 3, and 4, a multilayered expandable vascular stent comprises at least two layers of latticed support walls 10 and a cavity 20. An expandable balloon 30 is disposed in the cavity 20. The vascular vent is able to expand under the expansion of the balloon 30. The latticed support walls 10 in the outer layer have a relatively large expansion extent which exceeds the elongation percentage thereof, thus tend to break or damage, while the latticed support walls 10 in the inner layer have a relatively small expansion extent, and do not break and damage, thus ensuring the integrity of the vascular stent, and ensuring the vascular stent exhibits its role.

[0015] The latticed support walls are made of magnesium alloy material, which is degradable material and is degraded gradually with the time passing by. Thus, according to the requirement for service life, reasonable quantity of latticed support walls is preset. In general, there are at least two or three layers of latticed support walls. The latticed support walls in each layer are between 0.05 and 0.2 mm in thickness.

[0016] Preferably, surfaces of the latticed support walls are coated with a drug-loading layer. The drug-loading layer comprises a polymer and an active component. The polymer is an ethylene-vinyl alcohol copolymer, ethylene-vinyl acetate copolymer or styrene-isobutylene block copolymer. The active component is antiplatelet drug. The stent is arranged in the blood vessel to prevent the restenosis of the blood vessel thus achieving the purpose of dredging the blood vessel. So, it is necessary to coat antiplatelet drug on the blood vessel, for example, cilostazol, which not only has the function of antiplatelet, but also has the function of expanding blood vessel, inhibits the growth of vascular smooth muscle, and inhibits thrombosis, including vascular wall and endothelial cell.

[0017] Unless otherwise indicated, the numerical ranges involved in the invention include the end values. While particular embodiments of the invention have been shown and described, it will be obvious to those skilled in the art that changes and modifications may be made without departing from the invention in its broader aspects, and therefore, the aim in the appended claims is to cover all such changes and modifications as fall within the true spirit and scope of the invention.